Trial Profile
A self-emulsifying lipid suspension formulation enhances oral bioavailability of MP-470 in a randomized two-way crossover study in healthy male subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Apr 2010
Price :
$35
*
At a glance
- Drugs Amuvatinib (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Astex Pharmaceuticals